Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00221656
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
PZD | (11aS)-7,8-dimethoxy-2-naphthalen- 2-yl-1,10,11,11a-tetrahydro-5H- pyrrolo[2,1-c][1,4]benzodiazepin- 5-one | A,B | 2K4L | 0.71 | |
AL6 | 2-(3-METHOXYPHENYL)-2H-THIENO-[3,2- E]-1,2-THIAZINE-6-SULFINAMIDE-1,1- DIOXIDE | A | 1BN3 | 0.73 | |
ILC | A | 2FPV | 0.75 | ||
11M | 1-(1'-{[3-(methylsulfanyl)-2-benzothiophen- 1-yl]carbonyl}spiro[1-benzofuran- 3,4'-piperidin]-5-yl)methanamine | A,B,C,D | 2ZEB | 0.71 | |
VS3 | 3-[N-[BENZYLOXYCARBONYL]-PHENYLALANINYL- AMINO]-5-PHENYL-PENTANE-1-SULFONIC ACID 4- NITRO-PHENYL ESTER | A | 1F2B | 0.7 | |
CNO | 2-{4-[(3{2-[4-(1-CARBOXY-1-METHYL- ETHOXY)-PHENYL]-ACETYLAMINO}-PHENYLCARBAMOYL)- METHYL]-PHENOXY}-2-METHYL-PROPIONIC ACID | A,B,C,D | 1K0Y | 0.7 | |
HBY | (S)-4-ISOPROPOXYCARBONYL-6-METHOXY- 3-METHYLTHIOMETHYL-3,4-DIHYDROQUINOXALIN- 2(1H)-THIONE | A | 2IC3 | 0.71 | |
HBY | (S)-4-ISOPROPOXYCARBONYL-6-METHOXY- 3-METHYLTHIOMETHYL-3,4-DIHYDROQUINOXALIN- 2(1H)-THIONE | A | 1BQM | 0.71 | |
HBY | (S)-4-ISOPROPOXYCARBONYL-6-METHOXY- 3-METHYLTHIOMETHYL-3,4-DIHYDROQUINOXALIN- 2(1H)-THIONE | A | 1BQN | 0.71 | |
HBY | (S)-4-ISOPROPOXYCARBONYL-6-METHOXY- 3-METHYLTHIOMETHYL-3,4-DIHYDROQUINOXALIN- 2(1H)-THIONE | A | 1HQU | 0.71 | |
MUI | (5S)-3-(4-ACETYLPHENYL)-N-[(1S,2R)- 1-BENZYL-2-HYDROXY-3-{ISOBUTYL[(4- METHOXYPHENYL)SULFONYL]AMINO}PROPYL]- 2-OXO-1,3-OXAZOLIDINE-5-CARBOXAMIDE | A,B | 2I0A | 0.71 | |
RPF | 1-{4-[3-(2-METHOXY-BENZYLOXY)-PROPOXY]- PHENYL}-6-(1,2,,3,4-TETRAHYDRO- QUINOLIN-7-YLOXYMETHYL)-PIPERAZIN- 2-ONE | A,B | 2BKT | 0.75 | |
MSI | 1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE- 1-SULFONYL)-1H-INDOLE-2,3-DIONE | A | 1GFW | 0.7 | |
AL7 | (S)-3,4-DIHYDRO-2-(3-METHOXYPHENYL)- 4-METHYLAMINO-2H-THIENO[3,2-E]- 1,2-THIAZINE-6-SULFONAMIDE-1,1- DIOXIDE | A | 1BNV | 0.79 | |
4BS | 4-amino-N-[4-(benzyloxy)phenyl]butanamide | A | 3CHR | 0.7 | |
905 | (R)-4-[2-(3-AMINO-BENZENESULFONYLAMINO)- 1-(3,5-DIETHOXY-2-FLUOROPHENYL)- 2-OXO-ETHYLAMINO]-2-HYDROXY-BENZAMIDINE | H,L | 1YGC | 0.71 | |
D55 | 4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)- 3,5-dimethylbenzamide | A | 2VIQ | 0.72 | |
AXA | (5S)-5-(2-amino-2-oxoethyl)-4-oxo- N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin- 6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3- d]pyrimidine-2-carboxamide | A,B | 3DNG | 0.72 | |
B98 | (3R)-3-(aminomethyl)-9-methoxy- 1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2- e][1,4]diazepin-5-one | A | 3FZ1 | 0.76 | |
B98 | (3R)-3-(aminomethyl)-9-methoxy- 1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2- e][1,4]diazepin-5-one | X | 3FYK | 0.76 | |
006 | (4R)-3-[(2S,3S)-3-{[(2,6-dimethylphenoxy)acetyl]amino}- 2-hydroxy-4-phenylbutanoyl]-N-[(1S,2R)- 2-hydroxy-2,3-dihydro-1H-inden- 1-yl]-5,5-dimethyl-1,3-thiazolidine- 4-carboxamide | A,B,C,D | 3FNU | 0.71 | |
MUT | (5S)-3-(3-ACETYLPHENYL)-N-[(1S,2R)- 1-BENZYL-2-HYDROXY-3-{ISOBUTYL[(4- METHOXYPHENYL)SULFONYL]AMINO}PROPYL]- 2-OXO-1,3-OXAZOLIDINE-5-CARBOXAMIDE | A,B | 2I0D | 0.72 | |
PI9 | A,B | 1D4L | 0.73 | ||
L05 | 1-BENZYL-3-(4-METHOXYPHENYLAMINO)- 4-PHENYLPYRROLE-2,5-DIONE | A,B,C,D,E,F, G,H | 2ACL | 0.79 | |
410 | 4-bromo-3-(carboxymethoxy)-5-{3- [cyclohexyl(phenylcarbonyl)amino]phenyl}thiophene- 2-carboxylic acid | A | 2ZN7 | 0.7 | |
GVB | (3R,4S)-1-(3,4-DIMETHOXYPHENYL)- 3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE | A,B | 2JID | 0.7 | |
ZY3 | N-{(1S,2R)-1-BENZYL-2-HYDROXY-3- [(3-METHOXYBENZYL)AMINO]PROPYL}- 6-(ETHYLAMINO)-1-METHYL-1,3,4,5- TETRAHYDRO-2,1-BENZOTHIAZEPINE- 8-CARBOXAMIDE 2,2-DIOXIDE | A | 2WF3 | 0.71 | |
4BG | N-[4-(benzyloxy)phenyl]glycinamide | A | 3CHO | 0.71 | |
MZ3 | N-[(1S,2R)-1-BENZYL-2-HYDROXY-3- {[(3-METHOXYPHENYL)SULFONYL](2- THIENYLMETHYL)AMINO}PROPYL]-3-FLUORO- 2-METHYLBENZAMIDE | A,B | 2QI0 | 0.73 | |
ILF | A | 2FPY | 0.71 | ||
BSD | N-{(1S,2R)-1-benzyl-2-hydroxy-3- [(3-methoxybenzyl)amino]propyl}- 5-[methyl(methylsulfonyl)amino]- N'-[(1R)-1-phenylethyl]benzene- 1,3-dicarboxamide | A,B,C,D | 2VKM | 0.7 | |
INL | 6-[N-(3-METHOXY-PHENYL)-3-(MORPHOLIN- 4-YLMETHYL)-2H-THIENO[3,2-E]-1,2- THIAZINE-1,1,-DIOXIDE]-SULFONAMIDE | A | 1I8Z | 0.74 | |
4BO | (3S)-3-amino-4-oxo-4-[(4-phenylmethoxyphenyl)amino]butanoic acid | A | 3CHP | 0.7 | |
J12 | N-{3-[4-(3-AMINO-PROPYL)-PIPERAZIN- 1-YL]-PROPYL}-3-(2-THIOPHEN-2-YL- ACETYLAMINO)-5-(3,4,5-TRIHYDROXY- 6-HYDROXYMETHYL-TETRAHYDRO-PYRAN- 2-YLOXY)-BENZAMIDE | D,E,F,G,H | 1PZK | 0.77 | |
GNQ | N-[(1R)-1-[(BENZYLSULFONYL)METHYL]- 2-{[(1S)-1-METHYL-2-{[4-(TRIFLUOROMETHOXY)PHENYL]AMINO}ETHYL]AMINO}- 2-OXOETHYL]MORPHOLINE-4-CARBOXAMIDE | A,B | 2HHN | 0.75 | |
GNQ | N-[(1R)-1-[(BENZYLSULFONYL)METHYL]- 2-{[(1S)-1-METHYL-2-{[4-(TRIFLUOROMETHOXY)PHENYL]AMINO}ETHYL]AMINO}- 2-OXOETHYL]MORPHOLINE-4-CARBOXAMIDE | A,B | 2HH5 | 0.75 | |
AL8 | (R)-3,4-DIHYDRO-2-(3-METHOXYPHENYL)- 4-METHYLAMINO-2H-THIENO[3,2-E]- 1,2-THIAZINE-6-SULFONAMIDE-1,1- DIOXIDE | A | 1BNM | 0.79 | |
NOQ | (1R,2R)-N-(2-AMINOETHYL)-2-{[(4- METHOXYPHENYL)SULFONYL]METHYL}CYCLOHEXANECARBOXAMIDE | A | 2F7D | 0.72 | |
MZ4 | N-[(1S,2R)-1-BENZYL-2-HYDROXY-3- {[(3-METHOXYPHENYL)SULFONYL](2- THIENYLMETHYL)AMINO}PROPYL]-3,4- DIHYDROXYBENZAMIDE | A,B | 2QI1 | 0.72 | |
413 | (S)-[(R)-2-(4-BENZYLOXY-3-METHOXY- PHENYL)-2-(4-CARBAMIMIDOYL-PHENYLAMINO)- ACETYLAMINO]-PHENYL-ACETIC ACID | H,L | 1W7X | 0.71 | |
413 | (S)-[(R)-2-(4-BENZYLOXY-3-METHOXY- PHENYL)-2-(4-CARBAMIMIDOYL-PHENYLAMINO)- ACETYLAMINO]-PHENYL-ACETIC ACID | H | 1W8B | 0.71 | |
LIJ | BENZYL [(1S)-2-({(1S,2R)-1-BENZYL- 2-HYDROXY-3-[(3-METHOXYBENZYL)AMINO]PROPYL}AMINO)- 2-OXO-1-{[(1-PROPYLBUTYL)SULFONYL]METHYL}ETHYL]CARBAMATE | A,B,C | 2HIZ | 0.7 | |
T1D | 5-(4-METHOXYBIPHENYL-3-YL)-1,2,5- THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE | A | 2BGD | 0.71 | |
DRR | A,B | 3BXR | 0.71 | ||
012 | (4S)-N-[(1S,2R)-1-benzyl-3-{[3- (dimethylamino)benzyl]amino}-2- hydroxypropyl]-1-(3-methoxybenzyl)- 2-oxoimidazolidine-4-carboxamide | A,B,C | 3CKP | 0.74 | |
AL1 | 3,,4-DIHYDRO-2-(3-METHOXYPHENYL)- 2H-THIENO-[3,2-E]-1,2-THIAZINE- 6-SULFONAMIDE-1,1-DIOXIDE | A | 1BNN | 0.74 | |
R6G | RHODAMINE 6G | B | 2V3L | 0.7 | |
380 | (2R)-2-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO)- N-BENZYL-2-(3,4-DIMETHOXYPHENYL)ACETAMIDE | H,L | 1W2K | 0.76 | |
VG4 | N-[(1S,2R)-1-benzyl-3-{[(1S)-2- (cyclohexylamino)-1-methyl-2-oxoethyl]amino}- 2-hydroxypropyl]-3-(2-oxo-2,3-dihydro- 1H-pyrrol-1-yl)-5-propoxybenzamide | A | 2VIZ | 0.75 | |
CYF | 5-[2-(2-AMINO-2-CARBAMOYL-ETHYLSULFANYL)- ACETYLAMINO]-2-(3,6-DIHYDROXY-9,9A- DIHYDRO-3H-XANTHEN-9-YL)-BENZOIC ACID | L,P | 1MPA | 0.7 | |
CYF | 5-[2-(2-AMINO-2-CARBAMOYL-ETHYLSULFANYL)- ACETYLAMINO]-2-(3,6-DIHYDROXY-9,9A- DIHYDRO-3H-XANTHEN-9-YL)-BENZOIC ACID | L,P | 2MPA | 0.7 | |
CYF | 5-[2-(2-AMINO-2-CARBAMOYL-ETHYLSULFANYL)- ACETYLAMINO]-2-(3,6-DIHYDROXY-9,9A- DIHYDRO-3H-XANTHEN-9-YL)-BENZOIC ACID | I,L | 1DZH | 0.7 | |
BIQ | BENZYL [12-(2-AMINO-2-OXOETHYL)- 4-NITRO-10,13-DIOXO-15-[(PROPYLAMINO)CARBONYL]- 2-OXA-11,14-DIAZATRICYCLO[15 .2.2.1~3,7~]DOCOSA- 1(19),3(22),4,6,17,20-HEXAEN-9- YL]CARBAMATE | H,V | 2GPL | 0.7 |